Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Mexico City, Mexico City 14080

0 studies enrolling now · 12 studies all time

What they study most

Arthritis, Rheumatoid, COVID, COVID-19, Cardiovascular Disease, Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Covid19, Diabetes Type 2, Diffuse Cutaneous Systemic Sclerosis, IgG4 Related Disease, Kidney Neoplasms, Peripheral Vascular Disease, Pulmonary Hypertension

Studies at this site

• Outpatient Treatment With Anti-Coronavirus Immunoglobulin — Paused
• Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1) — Completed
• A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease — Running, not enrolling
• An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) — Stopped early
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early
• A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System — Completed
• Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — Completed
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• PF-00489791 For The Treatment Of Raynaud's — Completed